{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:25:40Z","timestamp":1791689140830,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.euo.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:22:12Z","timestamp":1697282532000},"page":"721-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4073-6584","authenticated-orcid":false,"given":"Pawel","family":"Rajwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Robesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chaloupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai A.","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Krzywon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Stando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Cisero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiya","family":"Semko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Checcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Apfelbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazan","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Dal Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bjartell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.09.006_b0005","unstructured":"National comprehensive Cancer Network. Prostate cancer (version 1.2023). 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.euo.2023.09.006_b0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.09.006_b0015","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-18-0768","article-title":"PSMA ligand PET\/MRI for primary prostate cancer: staging performance and clinical impact","volume":"24","author":"Grubmuller","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2023.09.006_b0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2022.06.100","article-title":"Imaging-based prevalence of oligometastatic disease: a single-center cross-sectional study","volume":"114","author":"Christ","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.09.006_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.eururo.2022.10.005","article-title":"More accurate imaging is not stage migration: time to move from \u201chubble\u201d to \u201cwebb\u201d in hormone-sensitive prostate cancer","volume":"83","author":"Ayati","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euo.2022.06.001","article-title":"Combination of androgen deprivation therapy with radical local therapy versus androgen deprivation therapy alone for newly diagnosed oligometastatic prostate cancer: a phase II randomized controlled trial","volume":"5","author":"Dai","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0035","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.09.006_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/EDBK_159241","article-title":"Approach to oligometastatic prostate cancer","volume":"36","author":"Bernard","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.euo.2023.09.006_b0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13014-021-01776-8","article-title":"Radiotherapy of oligometastatic prostate cancer: a systematic review","volume":"16","author":"Rogowski","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.urology.2016.10.044","article-title":"A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer","volume":"102","author":"O'Shaughnessy","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euo.2023.09.006_b0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2022.08.002","article-title":"Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis","volume":"82","author":"Yanagisawa","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MOU.0000000000000691","article-title":"Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease","volume":"30","author":"Heidenreich","year":"2020","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euo.2018.03.002","article-title":"Cytoreductive radical prostatectomy in men with prostate cancer and skeletal metastases","volume":"1","author":"Heidenreich","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2016.08.040","article-title":"Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.euf.2023.01.011","article-title":"Cytoreductive radical prostatectomy for metastatic hormone-sensitive prostate cancer\u2014 evidence from recent prospective reports","volume":"9","author":"Rajwa","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.09.006_b0080","doi-asserted-by":"crossref","first-page":"e2100543","DOI":"10.1200\/PO.21.00543","article-title":"Genomic features of lung-recurrent hormone-sensitive prostate cancer","volume":"6","author":"Fonseca","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0085","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2023.09.006_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.eururo.2009.11.034","article-title":"Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy","volume":"57","author":"Rabbani","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.euo.2023.09.006_b0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2012.07.007","article-title":"Randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy","volume":"63","author":"Porpiglia","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.euo.2023.09.006_b0120","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euo.2023.09.006_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euf.2019.05.008","article-title":"Enumeration and changes in circulating tumor cells and their prognostic value in patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer\u2014translational research results from the prospective ProMPT trial","volume":"7","author":"Mandel","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.09.006_b0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.eururo.2015.05.023","article-title":"A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation","volume":"69","author":"Sooriakumaran","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.euo.2023.09.006_b0140","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1038\/srep07713","article-title":"Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer","volume":"5","author":"Lei","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2023.09.006_b0145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2009.22.2265","article-title":"Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix","volume":"28","author":"Zelefsky","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bju.15553","article-title":"Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)","volume":"129","author":"Buelens","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.09.006_b0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/modpathol.2017.158","article-title":"Treatment effects in prostate cancer","volume":"31","author":"Evans","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euo.2023.09.006_b0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bju.14369","article-title":"Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardised reporting systems","volume":"122","author":"Pompe","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.09.006_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2016.05.008","article-title":"Robot-assisted radical prostatectomy and extended pelvic lymph node dissection in patients with locally-advanced prostate cancer","volume":"71","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0170","unstructured":"Mottet N, Conford P, van den Bergh RCN, et al. EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer. EAU Guidelines Office; 2022. https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"key":"10.1016\/j.euo.2023.09.006_b0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.euf.2020.09.021","article-title":"Clinical trial protocol for LuTectomy: a single-arm study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 prior to prostatectomy","volume":"7","author":"Dhiantravan","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.09.006_b0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2022.03.031","article-title":"Intensification of systemic therapy in addition to definitive local treatment in nonmetastatic unfavourable prostate cancer: a systematic review and meta-analysis","volume":"82","author":"Rajwa","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.09.006_b0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.euf.2022.10.013","article-title":"Surgical metastasectomy for visceral and bone prostate cancer metastases: a mini-review","volume":"9","author":"Rajwa","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.09.006_b0190","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0195","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1200\/JCO.2006.06.4246","article-title":"Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162)","volume":"24","author":"Hussain","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.09.006_b0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/cncr.24064","article-title":"Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy","volume":"115","author":"Choueiri","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2023.09.006_b0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.euf.2023.02.001","article-title":"Prostate-specific membrane antigen positron emission tomography as a biomarker to assess treatment response in patients with advanced prostate cancer","volume":"9","author":"Esen","year":"2023","journal-title":"Eur Urol Focus"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T06:15:19Z","timestamp":1721110519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2588931123001979"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.09.006","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}